Polymicrogyria and Congenital Parvovirus B19 Infection

Abstract

Fetal parvovirus B19 infection causes anemia, hydrops, and pregnancy loss but is generally not considered teratogenic. Nevertheless, disturbances of neuronal migration have been described with congenital parvovirus infection. We evaluated a term infant with congenital parvovirus disease and polymicrogyria. We compared this case with four other reports of central nervous system disease after birth to parvovirus-infected mothers. After an extensive diagnostic evaluation, this infant was found to have congenital parvovirus disease with severe anemia and nonimmune hydrops as well as extensive polymicrogyria. Although rare, this report and literature review suggest that parvovirus B19 has the potential to disrupt normal neurodevelopment. We suggest that infants with severe congenital parvovirus infection have close developmental surveillance and if symptomatic undergo neuroimaging to assess for disorders of neuromigration.

Keywords

Parvovirus - polymicrogyria - teratogen - congenital infection

• References

• 1 Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350: 586-597
• 2 Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513-518
• 3 Kumar ML, Abughali NF. Perinatal parvovirus B19 infection. NeoReviews 2005; 6: 32-37
• 4 Pistorius LR, Smal J, de Haan TR , et al. Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther 2008; 24: 491-494
• 5 Guerrini R, Parrini E. Neuronal migration disorders. Neurobiol Dis 2010; 38: 154-166
• 6 Leventer RJ, Jansen A, Pilz DT , et al. Clinical and imaging heterogeneity of polymicrogyria: a study of 328 patients. Brain 2010; 133 (Pt 5) 1415-1427
• 7 Brown KE, Green SW, Antunez de Mayolo J , et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-896
• 8 Heegaard ED, Hasle H, Clausen N, Hornsleth A, Kerndrup GB. Parvovirus B19 infection and Diamond-Blackfan anaemia. Acta Paediatr 1996; 85: 299-302
• 9 Katz VL, McCoy MC, Kuller JA, Hansen WF. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996; 13: 43-45
• 10 Isumi H, Nunoue T, Nishida A, Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 1999; 21: 661-663
• 11 Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174-178
• 12 Nagel HTC, de Haan TR, Vandenbussche FPHA, Oepkes D, Walther FJ. Long-term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007; 109: 42-47
• 13 Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hübinger AM, Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002; 109: 1232-1234
• 14 Savage AH, Anderson BL, Simhan HN. The safety of prolonged indomethacin therapy. Am J Perinatol 2007; 24: 207-213
• 15 Johnson RT. Viral infections and malformations of the nervous system. Birth Defects Orig Artic Ser 1971; 7: 56-63